Calizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Calizumab, covering 2023-07-28 to 2023-07-28. Get the full timeline:
Most recent: Clinical Trial Update: Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma [Phase 2]